An Integrated Closed-loop Feedback System for Pediatric Cardiometabolic Disease

NCT02659163 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2017-09-01

No results posted yet for this study

Summary

The high prevalence and burden of cardiometabolic disease underlie the urgent need to identify novel approaches to managing and preventing cardiometabolic disease and risk. This project will test an innovative use of mobile health technology to implement a closed-loop feedback system that collects objective patient-generated data and provides clinical recommendations to modify contributing health behaviors. In addition to improving care for cardiometabolic disease, the tools and methods developed by this study for collecting patient data and providing clinical feedback could also easily be adapted and applied to a range of other health conditions, and are thus highly relevant to public health.

Conditions

Interventions

BEHAVIORAL

mHealth wristband

A wristband containing several sensors worn by participants to collect daily objective patient-generated health behavior data on physical activity, sleep, and screen time

BEHAVIORAL

mHealth scale

A wireless scale used by participants to measure and record daily weight.

BEHAVIORAL

EMA

Self-reported information on sugar sweetened beverage consumption collected via mobile messaging

BEHAVIORAL

mHealth app

A mobile application that houses study data and provides two-way messaging between the study team and study participants.

BEHAVIORAL

Health Behavior Feedback

Provide feedback on patient-generated health behaviors data, along with standard of care recommendations, for self-guided

BEHAVIORAL

Integrated closed-loop feedback system

Daily feedback and weekly e-report cards on patient-generated longitudinal health behaviors along with clinical recommendations via mobile messaging

Sponsors & Collaborators

Principal Investigators

  • Nicolas M Oreskovic, MD, MPH · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-31
Primary Completion
2018-10-31
Completion
2018-10-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02659163 on ClinicalTrials.gov